Torsten Rüdiger Goesch
Chairman at BIOSERGEN AB
Profile
Torsten Rüdiger Goesch currently works at Biosergen AS, as Chairman, Dilafor AB, as Chairman, Biosergen AB, as Chairman from 2015, Forward Pharma A, as Director from 2006, Pergamum AB, as Director, KDev Oncology AB, as Director, Modus Therapeutics AB, as Director, Modus Therapeutics Holding AB, as Independent Director from 2014, Vistagen Pte Ltd., as Director, Goesch Pharma Pte Ltd., as Director, and Rosetta Capital Ltd., as Partner from 2002.
Dr. Goesch also formerly worked at Rosetta Capital I LP, as Director, TRG Investors LLC, as Managing Director from 1999 to 2002, EyeSense GmbH, as Director, STI Technologies Ltd., as Director, Promore Pharma AB, as Independent Director, Karolinska Development AB, as Director, KDev Investments AB, as Director, Cytochrome Ltd., as Director, Biogen MA, Inc., as General Manager-Central Europe from 1997 to 1999, and Merck Generics, as Commercial Head in 1995.
Dr. Goesch received his doctorate degree from Heinrich-Heine-Universität Düsseldorf and Masters Business Admin degree and doctorate degree from Kellogg School of Management.
Torsten Rüdiger Goesch active positions
| Companies | Position | Start |
|---|---|---|
| FORWARD PHARMA A/S | Director/Board Member | 2006-05-31 |
| MODUS THERAPEUTICS HOLDING AB | Director/Board Member | 2013-12-31 |
| BIOSERGEN AB | Chairman | 2014-12-31 |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Director/Board Member | - |
Goesch Pharma Pte Ltd.
 Goesch Pharma Pte Ltd. Medical DistributorsDistribution Services Goesch Pharma Pte Ltd. is a Singaporean company that wholesales pharmaceutical products. The private company is based in Singapore, Singapore. | Director/Board Member | - |
| Vistagen Pte Ltd. | Director/Board Member | - |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Chairman | - |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Director/Board Member | - |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Chairman | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Torsten Rüdiger Goesch
| Companies | Position | End |
|---|---|---|
| ░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Torsten Rüdiger Goesch
| Heinrich-Heine-Universität Düsseldorf | Doctorate Degree |
| Kellogg School of Management | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| KAROLINSKA DEVELOPMENT AB | Finance |
| MODUS THERAPEUTICS HOLDING AB | Health Technology |
| BIOSERGEN AB | Health Technology |
| Private companies | 18 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
| Rosetta Capital I LP | |
Rosetta Capital Ltd.
 Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital Ltd (Rosetta Capital) is a venture capital firm is founded in 2001 by Jeremy Curnock Cook, Michael Forer and Jonathan Hepple. The firm is headquartered in London. | Finance |
TRG Investors LLC
 TRG Investors LLC Investment ManagersFinance TRG Investors LLC is a hedge fund company located in Medina, Minnesota. They are a subsidiary of the Rahn Group. TRG Investors is affiliated with The Rahn Group | Finance |
EyeSense GmbH
 EyeSense GmbH Electronic Equipment/InstrumentsElectronic Technology EyeSense GmbH develops novel ophthalmic self-diagnostic systems for glucose monitoring of diabetes patients. It is developing two different diagnostic systems: An ophthalmic sensor which-once inserted on the eye-can be read out optically as frequently as wanted, without any pain and a continuous sensor, to be worn on the abdomen or upper arm. The firm with its innovative sensor technology able to offer two products that addresses different needs in blood glucose monitoring which are Continuous Glucose Sensor and Eye Sensor. The company was founded in 2006 and is headquartered in Großostheim, Germany. | Electronic Technology |
Forward Pharma A/S
 Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 2005 and is headquartered in Copenhagen, Denmark. | Health Technology |
Sti Technologies Ltd.
 Sti Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services STI Technologies Ltd. provides marketing solutions to the health care industry. The firm's SmartTechnology platform allows stakeholders-manufacturers, pharmacies, prescribers, and payers to optimize their patient relationships. It offers solutions for pre-launch planning, brand adoption, market uptake, revenue optimization, retention and adherence, and loss of exclusivity. The company was founded by William B. Adams and Gregory Patey in 2001 and is headquartered in Halifax, Canada. | Commercial Services |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Health Technology |
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
| Merck Generics | |
Pergamum AB
 Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Health Technology |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Commercial Services |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Health Technology |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Health Technology |
| Cytochrome Ltd. | |
| Vistagen Pte Ltd. | Miscellaneous |
Goesch Pharma Pte Ltd.
Goesch Pharma Pte Ltd. Medical DistributorsDistribution Services Goesch Pharma Pte Ltd. is a Singaporean company that wholesales pharmaceutical products. The private company is based in Singapore, Singapore. | Distribution Services |
- Stock Market
- Insiders
- Torsten Rüdiger Goesch
